On September 16, 2026, Ayble Health, the nation's leading AI-enabled virtual multidisciplinary GI clinic, announced the close of a $16 million oversubscribed Series A round led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice, and several individual strategic investors. The round brings Ayble's total capital raised to over $27 million. Wilson Sonsini Goodrich & Rosati advised Ayble on the transaction.

Ayble’s clinically validated care model is currently accessible to more than 80 million Americans through payer, employer, and health system partnerships. Earlier this month, Ayble also became the first digestive health provider available through Amazon’s Health Benefits Connector, further expanding access to its virtual GI care. With this funding, Ayble plans to further scale its clinically validated model and expand access for patients managing GI and autoimmune disease.

The Wilson Sonsini team that advised Ayble on the transaction includes:

Corporate
Megan Baier
Sonali Sanyal
Adam Belkebir
Annie Schroyer

Healthcare Regulatory
Andrea Linna
Eva Yin
Nawa Lodin
Seamus Taylor

Data, Privacy, and Cybersecurity
Daniel Chen

Technology Transactions
Vikki Nguyen
Chris Murray

For more information, please see Ayble’s news release.